ImmunoCellular Therapeutics, Ltd to Present at Future Leaders Conference on April 5th  
3/28/2013 6:31:15 AM

ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced that Andrew Gengos, Chief Executive Officer of ImmunoCellular, will present a corporate overview and business update at the BioCentury and Thomson Reuters 20th Annual Future Leaders in the Biotech Industry conference on Friday, April 5, 2013 at 11:00 am ET at the Millennium Broadway Hotel, New York City.